Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Charco JM, Eraña H, Venegas V, García-Martínez S, López-Moreno R, González-Miranda E, Pérez-Castro MÁ, Castilla J.

Pathogens. 2017 Dec 14;6(4). pii: E67. doi: 10.3390/pathogens6040067. Review.

2.

In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.

Eraña H, Fernández-Borges N, Elezgarai SR, Harrathi C, Charco JM, Chianini F, Dagleish MP, Ortega G, Millet Ó, Castilla J.

J Virol. 2017 Nov 30;91(24). pii: e01543-17. doi: 10.1128/JVI.01543-17. Print 2017 Dec 15.

PMID:
28978705
3.

Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.

Elezgarai SR, Fernández-Borges N, Eraña H, Sevillano AM, Charco JM, Harrathi C, Saá P, Gil D, Kong Q, Requena JR, Andréoletti O, Castilla J.

Sci Rep. 2017 Aug 29;7(1):9584. doi: 10.1038/s41598-017-09489-3.

4.

Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions.

Hu PP, Morales R, Duran-Aniotz C, Moreno-Gonzalez I, Khan U, Soto C.

J Biol Chem. 2016 Jun 10;291(24):12880-7. doi: 10.1074/jbc.M115.681791. Epub 2016 Apr 7.

5.

Strain-dependent profile of misfolded prion protein aggregates.

Morales R, Hu PP, Duran-Aniotz C, Moda F, Diaz-Espinoza R, Chen B, Bravo-Alegria J, Makarava N, Baskakov IV, Soto C.

Sci Rep. 2016 Feb 15;6:20526. doi: 10.1038/srep20526.

6.

Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Mays CE, van der Merwe J, Kim C, Haldiman T, McKenzie D, Safar JG, Westaway D.

J Virol. 2015 Dec;89(24):12418-26. doi: 10.1128/JVI.02142-15. Epub 2015 Sep 30.

7.
8.

A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers.

Noble GP, Wang DW, Walsh DJ, Barone JR, Miller MB, Nishina KA, Li S, Supattapone S.

PLoS Pathog. 2015 Jun 30;11(6):e1005017. doi: 10.1371/journal.ppat.1005017. eCollection 2015 Jun.

9.

Structural determinants of phenotypic diversity and replication rate of human prions.

Safar JG, Xiao X, Kabir ME, Chen S, Kim C, Haldiman T, Cohen Y, Chen W, Cohen ML, Surewicz WK.

PLoS Pathog. 2015 Apr 14;11(4):e1004832. doi: 10.1371/journal.ppat.1004832. eCollection 2015 Apr.

10.

Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ.

J Clin Invest. 2015 Apr;125(4):1485-96. doi: 10.1172/JCI79408. Epub 2015 Feb 23. Erratum in: J Clin Invest. 2015 Jun;125(6):2548. J Clin Invest. 2015 Apr;125(4):doi:10.1172/JCI82647..

11.

In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Faburay B, Tark D, Kanthasamy AG, Richt JA.

Prion. 2014;8(6):393-403. doi: 10.4161/19336896.2014.983753.

12.

Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Shikiya RA, Eckland TE, Young AJ, Bartz JC.

Prion. 2014;8(6):415-20. doi: 10.4161/19336896.2014.983759.

13.

Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.

Groveman BR, Kraus A, Raymond LD, Dolan MA, Anson KJ, Dorward DW, Caughey B.

J Biol Chem. 2015 Jan 9;290(2):1119-28. doi: 10.1074/jbc.M114.619627. Epub 2014 Nov 21.

14.

Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion.

Henderson DM, Davenport KA, Haley NJ, Denkers ND, Mathiason CK, Hoover EA.

J Gen Virol. 2015 Jan;96(Pt 1):210-9. doi: 10.1099/vir.0.069906-0. Epub 2014 Oct 10.

15.

Molecular modeling of prion transmission to humans.

Levavasseur E, Privat N, Martin JC, Simoneau S, Baron T, Flan B, Torres JM, Haïk S.

Viruses. 2014 Oct 2;6(10):3766-77. doi: 10.3390/v6103766.

16.

Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.

Sano K, Atarashi R, Ishibashi D, Nakagaki T, Satoh K, Nishida N.

J Virol. 2014 Oct;88(20):11791-801. doi: 10.1128/JVI.00585-14. Epub 2014 Jul 30.

17.

Preclinical detection of variant CJD and BSE prions in blood.

Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O.

PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun.

18.

Synthesis of high titer infectious prions with cofactor molecules.

Supattapone S.

J Biol Chem. 2014 Jul 18;289(29):19850-4. doi: 10.1074/jbc.R113.511329. Epub 2014 May 23. Review.

19.

Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Harischandra DS, Kondru N, Martin DP, Kanthasamy A, Jin H, Anantharam V, Kanthasamy AG.

Prion. 2014 Jan-Feb;8(1):143-53.

20.

Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.

Kurt TD, Bett C, Fernández-Borges N, Joshi-Barr S, Hornemann S, Rülicke T, Castilla J, Wüthrich K, Aguzzi A, Sigurdson CJ.

J Neurosci. 2014 Jan 15;34(3):1022-7. doi: 10.1523/JNEUROSCI.4636-13.2014.

Supplemental Content

Support Center